Global Influenza Vaccination Market Size, Status and Forecast 2024-2031

Report ID: 955012 | Published Date: Sep 2024 | No. of Page: 105 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Influenza Vaccination Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Egg Based
        1.2.3 Cell Culture
        1.2.4 Recombinant
    1.3 Market by Application
        1.3.1 Global Influenza Vaccination Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Research Organizations
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Influenza Vaccination Market Perspective (2016-2027)
    2.2 Influenza Vaccination Growth Trends by Regions
        2.2.1 Influenza Vaccination Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Influenza Vaccination Historic Market Share by Regions (2016-2021)
        2.2.3 Influenza Vaccination Forecasted Market Size by Regions (2022-2027)
    2.3 Influenza Vaccination Industry Dynamic
        2.3.1 Influenza Vaccination Market Trends
        2.3.2 Influenza Vaccination Market Drivers
        2.3.3 Influenza Vaccination Market Challenges
        2.3.4 Influenza Vaccination Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Influenza Vaccination Players by Revenue
        3.1.1 Global Top Influenza Vaccination Players by Revenue (2016-2021)
        3.1.2 Global Influenza Vaccination Revenue Market Share by Players (2016-2021)
    3.2 Global Influenza Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Influenza Vaccination Revenue
    3.4 Global Influenza Vaccination Market Concentration Ratio
        3.4.1 Global Influenza Vaccination Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Influenza Vaccination Revenue in 2020
    3.5 Influenza Vaccination Key Players Head office and Area Served
    3.6 Key Players Influenza Vaccination Product Solution and Service
    3.7 Date of Enter into Influenza Vaccination Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Influenza Vaccination Breakdown Data by Type
    4.1 Global Influenza Vaccination Historic Market Size by Type (2016-2021)
    4.2 Global Influenza Vaccination Forecasted Market Size by Type (2022-2027)

5 Influenza Vaccination Breakdown Data by Application
    5.1 Global Influenza Vaccination Historic Market Size by Application (2016-2021)
    5.2 Global Influenza Vaccination Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Influenza Vaccination Market Size (2016-2027)
    6.2 North America Influenza Vaccination Market Size by Type
        6.2.1 North America Influenza Vaccination Market Size by Type (2016-2021)
        6.2.2 North America Influenza Vaccination Market Size by Type (2022-2027)
        6.2.3 North America Influenza Vaccination Market Size by Type (2016-2027)
    6.3 North America Influenza Vaccination Market Size by Application
        6.3.1 North America Influenza Vaccination Market Size by Application (2016-2021)
        6.3.2 North America Influenza Vaccination Market Size by Application (2022-2027)
        6.3.3 North America Influenza Vaccination Market Size by Application (2016-2027)
    6.4 North America Influenza Vaccination Market Size by Country
        6.4.1 North America Influenza Vaccination Market Size by Country (2016-2021)
        6.4.2 North America Influenza Vaccination Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Influenza Vaccination Market Size (2016-2027)
    7.2 Europe Influenza Vaccination Market Size by Type
        7.2.1 Europe Influenza Vaccination Market Size by Type (2016-2021)
        7.2.2 Europe Influenza Vaccination Market Size by Type (2022-2027)
        7.2.3 Europe Influenza Vaccination Market Size by Type (2016-2027)
    7.3 Europe Influenza Vaccination Market Size by Application
        7.3.1 Europe Influenza Vaccination Market Size by Application (2016-2021)
        7.3.2 Europe Influenza Vaccination Market Size by Application (2022-2027)
        7.3.3 Europe Influenza Vaccination Market Size by Application (2016-2027)
    7.4 Europe Influenza Vaccination Market Size by Country
        7.4.1 Europe Influenza Vaccination Market Size by Country (2016-2021)
        7.4.2 Europe Influenza Vaccination Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Influenza Vaccination Market Size (2016-2027)
    8.2 Asia-Pacific Influenza Vaccination Market Size by Type
        8.2.1 Asia-Pacific Influenza Vaccination Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Influenza Vaccination Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Influenza Vaccination Market Size by Type (2016-2027)
    8.3 Asia-Pacific Influenza Vaccination Market Size by Application
        8.3.1 Asia-Pacific Influenza Vaccination Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Influenza Vaccination Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Influenza Vaccination Market Size by Application (2016-2027)
    8.4 Asia-Pacific Influenza Vaccination Market Size by Region
        8.4.1 Asia-Pacific Influenza Vaccination Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Influenza Vaccination Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Influenza Vaccination Market Size (2016-2027)
    9.2 Latin America Influenza Vaccination Market Size by Type
        9.2.1 Latin America Influenza Vaccination Market Size by Type (2016-2021)
        9.2.2 Latin America Influenza Vaccination Market Size by Type (2022-2027)
        9.2.3 Latin America Influenza Vaccination Market Size by Type (2016-2027)
    9.3 Latin America Influenza Vaccination Market Size by Application
        9.3.1 Latin America Influenza Vaccination Market Size by Application (2016-2021)
        9.3.2 Latin America Influenza Vaccination Market Size by Application (2022-2027)
        9.3.3 Latin America Influenza Vaccination Market Size by Application (2016-2027)
    9.4 Latin America Influenza Vaccination Market Size by Country
        9.4.1 Latin America Influenza Vaccination Market Size by Country (2016-2021)
        9.4.2 Latin America Influenza Vaccination Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Influenza Vaccination Market Size (2016-2027)
    10.2 Middle East & Africa Influenza Vaccination Market Size by Type
        10.2.1 Middle East & Africa Influenza Vaccination Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Influenza Vaccination Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Influenza Vaccination Market Size by Type (2016-2027)
    10.3 Middle East & Africa Influenza Vaccination Market Size by Application
        10.3.1 Middle East & Africa Influenza Vaccination Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Influenza Vaccination Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Influenza Vaccination Market Size by Application (2016-2027)
    10.4 Middle East & Africa Influenza Vaccination Market Size by Country
        10.4.1 Middle East & Africa Influenza Vaccination Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Influenza Vaccination Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott (U.S.)
        11.1.1 Abbott (U.S.) Company Details
        11.1.2 Abbott (U.S.) Business Overview
        11.1.3 Abbott (U.S.) Influenza Vaccination Introduction
        11.1.4 Abbott (U.S.) Revenue in Influenza Vaccination Business (2016-2021)
        11.1.5 Abbott (U.S.) Recent Development
    11.2 AstraZeneca (Europe)
        11.2.1 AstraZeneca (Europe) Company Details
        11.2.2 AstraZeneca (Europe) Business Overview
        11.2.3 AstraZeneca (Europe) Influenza Vaccination Introduction
        11.2.4 AstraZeneca (Europe) Revenue in Influenza Vaccination Business (2016-2021)
        11.2.5 AstraZeneca (Europe) Recent Development
    11.3 BioCryst Pharmaceuticals (U.S.)
        11.3.1 BioCryst Pharmaceuticals (U.S.) Company Details
        11.3.2 BioCryst Pharmaceuticals (U.S.) Business Overview
        11.3.3 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Introduction
        11.3.4 BioCryst Pharmaceuticals (U.S.) Revenue in Influenza Vaccination Business (2016-2021)
        11.3.5 BioCryst Pharmaceuticals (U.S.) Recent Development
    11.4 Novartis (Europe)
        11.4.1 Novartis (Europe) Company Details
        11.4.2 Novartis (Europe) Business Overview
        11.4.3 Novartis (Europe) Influenza Vaccination Introduction
        11.4.4 Novartis (Europe) Revenue in Influenza Vaccination Business (2016-2021)
        11.4.5 Novartis (Europe) Recent Development
    11.5 DAIICHI SANKYO COMPANY (Asia Pacific)
        11.5.1 DAIICHI SANKYO COMPANY (Asia Pacific) Company Details
        11.5.2 DAIICHI SANKYO COMPANY (Asia Pacific) Business Overview
        11.5.3 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Introduction
        11.5.4 DAIICHI SANKYO COMPANY (Asia Pacific) Revenue in Influenza Vaccination Business (2016-2021)
        11.5.5 DAIICHI SANKYO COMPANY (Asia Pacific) Recent Development
    11.6 GlaxoSmithKline (Europe)
        11.6.1 GlaxoSmithKline (Europe) Company Details
        11.6.2 GlaxoSmithKline (Europe) Business Overview
        11.6.3 GlaxoSmithKline (Europe) Influenza Vaccination Introduction
        11.6.4 GlaxoSmithKline (Europe) Revenue in Influenza Vaccination Business (2016-2021)
        11.6.5 GlaxoSmithKline (Europe) Recent Development
    11.7 Hualan Biological Engineering (Asia Pacific)
        11.7.1 Hualan Biological Engineering (Asia Pacific) Company Details
        11.7.2 Hualan Biological Engineering (Asia Pacific) Business Overview
        11.7.3 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Introduction
        11.7.4 Hualan Biological Engineering (Asia Pacific) Revenue in Influenza Vaccination Business (2016-2021)
        11.7.5 Hualan Biological Engineering (Asia Pacific) Recent Development
    11.8 Mitsubishi Tanabe Pharma (Asia Pacific)
        11.8.1 Mitsubishi Tanabe Pharma (Asia Pacific) Company Details
        11.8.2 Mitsubishi Tanabe Pharma (Asia Pacific) Business Overview
        11.8.3 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Introduction
        11.8.4 Mitsubishi Tanabe Pharma (Asia Pacific) Revenue in Influenza Vaccination Business (2016-2021)
        11.8.5 Mitsubishi Tanabe Pharma (Asia Pacific) Recent Development
    11.9 F. Hoffmann-La Roche (Europe)
        11.9.1 F. Hoffmann-La Roche (Europe) Company Details
        11.9.2 F. Hoffmann-La Roche (Europe) Business Overview
        11.9.3 F. Hoffmann-La Roche (Europe) Influenza Vaccination Introduction
        11.9.4 F. Hoffmann-La Roche (Europe) Revenue in Influenza Vaccination Business (2016-2021)
        11.9.5 F. Hoffmann-La Roche (Europe) Recent Development
    11.10 Sanofi (Europe)
        11.10.1 Sanofi (Europe) Company Details
        11.10.2 Sanofi (Europe) Business Overview
        11.10.3 Sanofi (Europe) Influenza Vaccination Introduction
        11.10.4 Sanofi (Europe) Revenue in Influenza Vaccination Business (2016-2021)
        11.10.5 Sanofi (Europe) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Influenza Vaccination Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Egg Based
    Table 3. Key Players of Cell Culture
    Table 4. Key Players of Recombinant
    Table 5. Global Influenza Vaccination Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Influenza Vaccination Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Influenza Vaccination Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Influenza Vaccination Market Share by Regions (2016-2021)
    Table 9. Global Influenza Vaccination Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Influenza Vaccination Market Share by Regions (2022-2027)
    Table 11. Influenza Vaccination Market Trends
    Table 12. Influenza Vaccination Market Drivers
    Table 13. Influenza Vaccination Market Challenges
    Table 14. Influenza Vaccination Market Restraints
    Table 15. Global Influenza Vaccination Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Influenza Vaccination Market Share by Players (2016-2021)
    Table 17. Global Top Influenza Vaccination Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccination as of 2020)
    Table 18. Ranking of Global Top Influenza Vaccination Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Influenza Vaccination Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Influenza Vaccination Product Solution and Service
    Table 22. Date of Enter into Influenza Vaccination Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Influenza Vaccination Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Influenza Vaccination Revenue Market Share by Type (2016-2021)
    Table 26. Global Influenza Vaccination Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Influenza Vaccination Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Influenza Vaccination Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Influenza Vaccination Revenue Market Share by Application (2016-2021)
    Table 30. Global Influenza Vaccination Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Influenza Vaccination Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Influenza Vaccination Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Influenza Vaccination Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Influenza Vaccination Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Influenza Vaccination Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Influenza Vaccination Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Influenza Vaccination Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Influenza Vaccination Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Influenza Vaccination Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Influenza Vaccination Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Influenza Vaccination Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Influenza Vaccination Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Influenza Vaccination Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Influenza Vaccination Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Influenza Vaccination Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Influenza Vaccination Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Influenza Vaccination Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Influenza Vaccination Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Influenza Vaccination Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Influenza Vaccination Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Influenza Vaccination Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Influenza Vaccination Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Influenza Vaccination Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Influenza Vaccination Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Influenza Vaccination Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Influenza Vaccination Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Influenza Vaccination Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Influenza Vaccination Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Influenza Vaccination Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Influenza Vaccination Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Influenza Vaccination Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Abbott (U.S.) Company Details
    Table 63. Abbott (U.S.) Business Overview
    Table 64. Abbott (U.S.) Influenza Vaccination Product
    Table 65. Abbott (U.S.) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
    Table 66. Abbott (U.S.) Recent Development
    Table 67. AstraZeneca (Europe) Company Details
    Table 68. AstraZeneca (Europe) Business Overview
    Table 69. AstraZeneca (Europe) Influenza Vaccination Product
    Table 70. AstraZeneca (Europe) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
    Table 71. AstraZeneca (Europe) Recent Development
    Table 72. BioCryst Pharmaceuticals (U.S.) Company Details
    Table 73. BioCryst Pharmaceuticals (U.S.) Business Overview
    Table 74. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product
    Table 75. BioCryst Pharmaceuticals (U.S.) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
    Table 76. BioCryst Pharmaceuticals (U.S.) Recent Development
    Table 77. Novartis (Europe) Company Details
    Table 78. Novartis (Europe) Business Overview
    Table 79. Novartis (Europe) Influenza Vaccination Product
    Table 80. Novartis (Europe) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
    Table 81. Novartis (Europe) Recent Development
    Table 82. DAIICHI SANKYO COMPANY (Asia Pacific) Company Details
    Table 83. DAIICHI SANKYO COMPANY (Asia Pacific) Business Overview
    Table 84. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product
    Table 85. DAIICHI SANKYO COMPANY (Asia Pacific) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
    Table 86. DAIICHI SANKYO COMPANY (Asia Pacific) Recent Development
    Table 87. GlaxoSmithKline (Europe) Company Details
    Table 88. GlaxoSmithKline (Europe) Business Overview
    Table 89. GlaxoSmithKline (Europe) Influenza Vaccination Product
    Table 90. GlaxoSmithKline (Europe) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
    Table 91. GlaxoSmithKline (Europe) Recent Development
    Table 92. Hualan Biological Engineering (Asia Pacific) Company Details
    Table 93. Hualan Biological Engineering (Asia Pacific) Business Overview
    Table 94. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product
    Table 95. Hualan Biological Engineering (Asia Pacific) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
    Table 96. Hualan Biological Engineering (Asia Pacific) Recent Development
    Table 97. Mitsubishi Tanabe Pharma (Asia Pacific) Company Details
    Table 98. Mitsubishi Tanabe Pharma (Asia Pacific) Business Overview
    Table 99. Mitsubishi Tanabe Pharma (Asia Pacific) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
    Table 100. Mitsubishi Tanabe Pharma (Asia Pacific) Recent Development
    Table 101. F. Hoffmann-La Roche (Europe) Company Details
    Table 102. F. Hoffmann-La Roche (Europe) Business Overview
    Table 103. F. Hoffmann-La Roche (Europe) Influenza Vaccination Product
    Table 104. F. Hoffmann-La Roche (Europe) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
    Table 105. F. Hoffmann-La Roche (Europe) Recent Development
    Table 106. Sanofi (Europe) Company Details
    Table 107. Sanofi (Europe) Business Overview
    Table 108. Sanofi (Europe) Influenza Vaccination Product
    Table 109. Sanofi (Europe) Revenue in Influenza Vaccination Business (2016-2021) & (US$ Million)
    Table 110. Sanofi (Europe) Recent Development
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Influenza Vaccination Market Share by Type: 2020 VS 2027
    Figure 2. Egg Based Features
    Figure 3. Cell Culture Features
    Figure 4. Recombinant Features
    Figure 5. Global Influenza Vaccination Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals Case Studies
    Figure 7. Research Organizations Case Studies
    Figure 8. Influenza Vaccination Report Years Considered
    Figure 9. Global Influenza Vaccination Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Influenza Vaccination Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Influenza Vaccination Market Share by Regions: 2020 VS 2027
    Figure 12. Global Influenza Vaccination Market Share by Regions (2022-2027)
    Figure 13. Global Influenza Vaccination Market Share by Players in 2020
    Figure 14. Global Top Influenza Vaccination Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccination as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Influenza Vaccination Revenue in 2020
    Figure 16. Global Influenza Vaccination Revenue Market Share by Type (2016-2021)
    Figure 17. Global Influenza Vaccination Revenue Market Share by Type (2022-2027)
    Figure 18. North America Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Influenza Vaccination Market Share by Type (2016-2027)
    Figure 20. North America Influenza Vaccination Market Share by Application (2016-2027)
    Figure 21. North America Influenza Vaccination Market Share by Country (2016-2027)
    Figure 22. United States Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Influenza Vaccination Market Share by Type (2016-2027)
    Figure 26. Europe Influenza Vaccination Market Share by Application (2016-2027)
    Figure 27. Europe Influenza Vaccination Market Share by Country (2016-2027)
    Figure 28. Germany Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Influenza Vaccination Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Influenza Vaccination Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Influenza Vaccination Market Share by Region (2016-2027)
    Figure 38. China Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Influenza Vaccination Market Share by Type (2016-2027)
    Figure 46. Latin America Influenza Vaccination Market Share by Application (2016-2027)
    Figure 47. Latin America Influenza Vaccination Market Share by Country (2016-2027)
    Figure 48. Mexico Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Influenza Vaccination Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Influenza Vaccination Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Influenza Vaccination Market Share by Country (2016-2027)
    Figure 54. Turkey Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Influenza Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Abbott (U.S.) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
    Figure 58. AstraZeneca (Europe) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
    Figure 59. BioCryst Pharmaceuticals (U.S.) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
    Figure 60. Novartis (Europe) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
    Figure 61. DAIICHI SANKYO COMPANY (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
    Figure 62. GlaxoSmithKline (Europe) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
    Figure 63. Hualan Biological Engineering (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
    Figure 64. Mitsubishi Tanabe Pharma (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
    Figure 65. F. Hoffmann-La Roche (Europe) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
    Figure 66. Sanofi (Europe) Revenue Growth Rate in Influenza Vaccination Business (2016-2021)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott (U.S.)
AstraZeneca (Europe)
BioCryst Pharmaceuticals (U.S.)
Novartis (Europe)
DAIICHI SANKYO COMPANY (Asia Pacific)
GlaxoSmithKline (Europe)
Hualan Biological Engineering (Asia Pacific)
Mitsubishi Tanabe Pharma (Asia Pacific)
F. Hoffmann-La Roche (Europe)
Sanofi (Europe)
Frequently Asked Questions
Influenza Vaccination report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Influenza Vaccination report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Influenza Vaccination report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports